Clinical Trial Update: Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial compares escitalopram and reboxetine to assess gastrointestinal sensitivity in patients with major depressive disorder. The document…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Pain
• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)
• Reboxetine (Reboxetine)

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Major Depression, Pain | Phase 4 | Status: UNKNOWN